# Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

> **NCT03127358** · NA · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 11 (actual)

## Conditions studied

- Hepatitis C
- Medication Adherence

## Interventions

- **DEVICE:** AiCure
- **DEVICE:** AiCure with gamification

## Key facts

- **NCT ID:** NCT03127358
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127358, "Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03127358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*